BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 580566)

  • 1. [Relationship between the pathomorphological characteristics of the lungs and surfactant properties in some forms of chronic pneumonia].
    Nesterov EN; Panevskaia GN; Kobozev GV
    Arkh Patol; 1978; 40(3):54-8. PubMed ID: 580566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surface-active factor of the lungs (surfactant) in certain diseases of the respiratory organs].
    Puchkov GF; Iazvinskiĭ II
    Sov Med; 1975 Aug; (8):62. PubMed ID: 1105810
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the activity of surfactant in pulmonary emphysema and pneumosclerosis].
    Dudnikova GN
    Biull Eksp Biol Med; 1973 Feb; 74(2):17-20. PubMed ID: 4808336
    [No Abstract]   [Full Text] [Related]  

  • 4. [Surfactant surface activity and ultrastructural changes in the type-II alveolocytes of fetal and neonatal lungs in experimental inflammation of the maternal lungs].
    Zagorul'ko AK; Fat LF; Safronova LG; Kobozev GV; Gorelik NI
    Biull Eksp Biol Med; 1989 Jun; 107(6):753-6. PubMed ID: 2790177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The surfactant system of patients with chronic suppurative diseases of the lungs undergoing surgical treatment].
    Zagorul'ko AK; Zhuchkov AG; Birkun AA; Sokolov SB; Safronova LG
    Grudn Khir; 1988; (2):60-3. PubMed ID: 3384354
    [No Abstract]   [Full Text] [Related]  

  • 6. [An index of the stability of pulmonary alveoli, determining the state of surfactant in patients with chronic lung diseases].
    Barinova MV
    Eksp Khir Anesteziol; 1972; 17(1):78-81. PubMed ID: 5068520
    [No Abstract]   [Full Text] [Related]  

  • 7. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.
    Gregory TJ; Longmore WJ; Moxley MA; Whitsett JA; Reed CR; Fowler AA; Hudson LD; Maunder RJ; Crim C; Hyers TM
    J Clin Invest; 1991 Dec; 88(6):1976-81. PubMed ID: 1752956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
    Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
    Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Velocity of the pulse wave spread in patients with chronic nonspecific diseases of the lungs].
    Berezhnitskiĭ MN
    Vrach Delo; 1968 Sep; 9():12-4. PubMed ID: 5740292
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ultrastructure of the blood-air barrier in comparison with the indices of surfactant surface activity].
    Zagorul'ko AK; Birkun AA; Kobozev GV; Safronova LG
    Biull Eksp Biol Med; 1988 Nov; 106(11):617-21. PubMed ID: 3196869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary surfactant status in experimental dust-induced bronchitis based on the data from dynamic interphase tensiometry].
    Siniachenko OV; Korzh EV; Kazakov VN; Belokon' AM; Shcherbakov KS; Vladzimirskiĭ AV
    Med Tr Prom Ekol; 1999; (10):21-5. PubMed ID: 10568314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interrelation between the lipid composition of expirates and lung ventilation function in patients with acute pneumonia].
    Gel'tser BI; Khasina MA; Sobina AI
    Ter Arkh; 1990; 62(12):20-3. PubMed ID: 2084915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of factors influencing lung stability: biochemical changes of pulmonary surfactant and morphological changes of terminal air spaces in the developing rat.
    Suzuki Y; Tabata R; Okawa KI
    Jpn J Exp Med; 1978 Aug; 48(4):345-53. PubMed ID: 581391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The state of the surfactant system and postoperative lung complications].
    Leosko VA; Moshko IA
    Vestn Khir Im I I Grek; 1980 Aug; 125(8):9-13. PubMed ID: 6106976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The structural changes in the lungs and the phospholipids of the pulmonary surfactant in experimental bleomycin-induced pneumosclerosis in rats].
    Loshakova LV; Kirillov IuA; Lebedeva ES; Shul'ga AE; Zlotnikova LA; Alekseevskikh IuG; Danilov LN; Rozenberg OA
    Biull Eksp Biol Med; 1991 Nov; 112(11):534-6. PubMed ID: 1725757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of the "surfactant system" in some respiratory tract diseases].
    Condorelli S; Cosmi EV; Scarpelli EM
    Acta Anaesthesiol; 1970; 31():Suppl:49-67. PubMed ID: 5538012
    [No Abstract]   [Full Text] [Related]  

  • 17. [Change in the antiradical activity of surfactant lipids during the development of nonspecific inflammatory processes in rabbit bronchopulmonary tissue].
    Panevskaia GN; Iarosh AM; Nesterov EN
    Vopr Med Khim; 1978; 24(3):412-5. PubMed ID: 580818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on bronchiectasis. II. Macrosection study of the resected lungs of bronchiectasis].
    Ashimoto K
    Kobe Ika Daigaku Kiyo; 1965 Mar; 27(1):161-8. PubMed ID: 5298084
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lung surface tension in acute respiratory infections].
    Tsinzerling AV; Papaian AV; Baryshek OL
    Arkh Patol; 1978; 40(9):23-9. PubMed ID: 581347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change in the state of surfactant in experimental pneumonia].
    Panovskaia GN; Iashchenko LV; Nesterov EN; Kobozov GV
    Biull Eksp Biol Med; 1977 Sep; 84(9):286-8. PubMed ID: 578780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.